Equities research analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of CALA opened at $0.00 on Wednesday. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Why Are Stock Sectors Important to Successful Investing?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- The How And Why of Investing in Oil Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
